The "Non-Insulin Therapies for the Diabetes Market2020-2027 Research Report is a specialized and in-depth study of the Non-Insulin Therapies for the Diabetes Industry with...
Bigfoot Biomedical announced today that it has received $ 57 million in funding to commercialize its diabetes management program.
Madryn Asset Management provided funding for...